These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

482 related items for PubMed ID: 22931381

  • 1. Detection of complement-fixing and non-fixing antibodies specific for endothelial precursor cells and lymphocytes using flow cytometry.
    AlMahri A, Holgersson J, Alheim M.
    Tissue Antigens; 2012 Nov; 80(5):404-15. PubMed ID: 22931381
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [C4d]FlowPRA screening--a specific assay for selective detection of complement-activating anti-HLA alloantibodies.
    Wahrmann M, Exner M, Haidbauer B, Schillinger M, Regele H, Körmöczi G, Böhmig GA.
    Hum Immunol; 2005 May; 66(5):526-34. PubMed ID: 15935890
    [Abstract] [Full Text] [Related]

  • 4. Clinical relevance of complement-fixing antibodies in cardiac transplantation.
    Rose ML, Smith JD.
    Hum Immunol; 2009 Aug; 70(8):605-9. PubMed ID: 19375471
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Preformed complement-activating low-level donor-specific antibody predicts early antibody-mediated rejection in renal allografts.
    Lawrence C, Willicombe M, Brookes PA, Santos-Nunez E, Bajaj R, Cook T, Roufosse C, Taube D, Warrens AN.
    Transplantation; 2013 Jan 27; 95(2):341-6. PubMed ID: 23197178
    [Abstract] [Full Text] [Related]

  • 9. Cytotoxic flow cytometric crossmatch in renal transplantation: a single assay to simultaneously detect antibody binding and cytotoxicity.
    Thammanichanond D, Athimang W, Paisooksantivatana K, Mongkolsuk T, Ingsathit A, Worawichawong S, Kitpoka P, Jirasiritham S, Kantachuvesiri S.
    Transplant Proc; 2012 Jan 27; 44(1):62-5. PubMed ID: 22310580
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Consensus guidelines on the testing and clinical management issues associated with HLA and non-HLA antibodies in transplantation.
    Tait BD, Süsal C, Gebel HM, Nickerson PW, Zachary AA, Claas FH, Reed EF, Bray RA, Campbell P, Chapman JR, Coates PT, Colvin RB, Cozzi E, Doxiadis II, Fuggle SV, Gill J, Glotz D, Lachmann N, Mohanakumar T, Suciu-Foca N, Sumitran-Holgersson S, Tanabe K, Taylor CJ, Tyan DB, Webster A, Zeevi A, Opelz G.
    Transplantation; 2013 Jan 15; 95(1):19-47. PubMed ID: 23238534
    [Abstract] [Full Text] [Related]

  • 12. Solid phase detection of C4d-fixing HLA antibodies to predict rejection in high immunological risk kidney transplant recipients.
    Bartel G, Wahrmann M, Schwaiger E, Kikić Ž, Winzer C, Hörl WH, Mühlbacher F, Hoke M, Zlabinger GJ, Regele H, Böhmig GA.
    Transpl Int; 2013 Feb 15; 26(2):121-30. PubMed ID: 23145861
    [Abstract] [Full Text] [Related]

  • 13. C1q assay for the detection of complement fixing antibody to HLA antigens.
    Chen G, Tyan DB.
    Methods Mol Biol; 2013 Feb 15; 1034():305-11. PubMed ID: 23775744
    [Abstract] [Full Text] [Related]

  • 14. Systematic comparison of four cell- and Luminex-based methods for assessment of complement-activating HLA antibodies.
    Lachmann N, Todorova K, Schulze H, Schönemann C.
    Transplantation; 2013 Mar 15; 95(5):694-700. PubMed ID: 23354296
    [Abstract] [Full Text] [Related]

  • 15. The outcome of the endothelial precursor cell crossmatch test in lymphocyte crossmatch positive and negative patients evaluated for living donor kidney transplantation.
    Alheim M, AlMahri A, Nilsson J, Tydén G, Holgersson J.
    Hum Immunol; 2013 Nov 15; 74(11):1437-44. PubMed ID: 23777925
    [Abstract] [Full Text] [Related]

  • 16. C1q-fixing human leukocyte antigen assay in immunized renal patients: correlation between Luminex SAB-C1q and SAB-IgG.
    Llorente S, Boix F, Eguia J, López M, Bosch A, Martinez H, Gonzalez MJ, López-Hernández R, Salgado G, Moya-Quiles MR, Campillo JA, García-Alonso AM, Minguela A, Jimeno L, Alvarez-López MR, Muro M.
    Transplant Proc; 2012 Nov 15; 44(9):2535-7. PubMed ID: 23146446
    [Abstract] [Full Text] [Related]

  • 17. Clinical impact of complement (C1q, C3d) binding De Novo donor-specific HLA antibody in kidney transplant recipients.
    Lee H, Han E, Choi AR, Ban TH, Chung BH, Yang CW, Choi YJ, Oh EJ.
    PLoS One; 2018 Nov 15; 13(11):e0207434. PubMed ID: 30427941
    [Abstract] [Full Text] [Related]

  • 18. Alloantibodies and the outcome of cadaver kidney allografts.
    Vasilescu ER, Ho EK, Colovai AI, Vlad G, Foca-Rodi A, Markowitz GS, D'Agati V, Hardy MA, Ratner LE, Suciu-Foca N.
    Hum Immunol; 2006 Aug 15; 67(8):597-604. PubMed ID: 16916655
    [Abstract] [Full Text] [Related]

  • 19. Detection of Complement-binding Donor-specific Antibodies, Not IgG-antibody Strength Nor C4d Status, at Antibody-mediated Rejection Diagnosis Is an Independent Predictor of Kidney Graft Failure.
    Malheiro J, Santos S, Tafulo S, Dias L, Martins S, Fonseca I, Almeida M, Pedroso S, Beirão I, Castro-Henriques A, Cabrita A.
    Transplantation; 2018 Nov 15; 102(11):1943-1954. PubMed ID: 29757900
    [Abstract] [Full Text] [Related]

  • 20. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
    Lee PC, Ozawa M.
    Clin Transpl; 2007 Nov 15; ():219-26. PubMed ID: 18642453
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.